Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free NVO Stock Alerts

Novo Nordisk A/S (NVO) Earnings Date, Estimates & Call Transcripts

Novo Nordisk A/S logo
$46.10 -0.29 (-0.61%)
As of 02:52 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Novo Nordisk A/S Earnings Summary

Novo Nordisk A/S posted Q2 2026 earnings on August 5, 2026, reporting an EPS of $0.96, which topped the consensus estimate of $0.77 by $0.19. Quarterly revenue was reported to be $11.98 billion, above analyst estimates of $10.89 billion. With a trailing EPS of $4.09 and a P/E Ratio of 11.23, Novo Nordisk A/S's earnings are expected to decrease -2.36% next year, from $3.39 to $3.31 per share.

Latest Q2
Earnings Date
Aug. 5Estimated
Consensus EPS
(Aug. 5)
$0.77
Actual EPS
(Aug. 5)
$0.96 Beat By $0.19
Actual Revenue
(Aug. 5)
$11.98B

Q2 2026 Earnings Resources

Slide Deck

Novo Nordisk A/S's Q2 2026 Slide DeckFull Screen Slide Deck
Powered by Quartr
Get Novo Nordisk A/S Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Novo Nordisk A/S and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

NVO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NVO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Novo Nordisk A/S Analyst EPS Estimates

Current Year EPS Consensus Estimate
$3.39 EPS
Next Year EPS Consensus Estimate
$3.31 EPS

Novo Nordisk A/S Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/5/2026Q2 2026$0.77$0.96+$0.19$0.72$10.89B$11.98B
6/30/2026Q2 2026-$0.9440-$0.72-$11.98B
5/6/2026Q1 2026$0.87$1.04+$0.17$1.69$10.86B$10.85B
3/31/2026Q1 2026-$1.0270-$1.69-$10.85B
2/3/2026Q4 2025$0.90$1.0120+$0.1120$0.95$11.97B$12.43B
11/5/2025Q3 2025$0.77$1.02+$0.25$0.71$11.98B$11.79B
8/6/2025Q2 2025 $0.93$0.97+$0.04$0.91$77.51B$11.69B
5/7/2025Q1 2025$0.92$0.92-$0.92-$11.87B
2/5/2025Q4 2024$0.88$0.91+$0.03$0.91--

Novo Nordisk A/S Earnings - Frequently Asked Questions

Novo Nordisk A/S (NYSE:NVO) last announced its quarterly earning data on Wednesday, August 5, 2026. Learn more on NVO's earnings history.

In the previous quarter, Novo Nordisk A/S (NYSE:NVO) reported $0.96 earnings per share (EPS) to beat the analysts' consensus estimate of $0.77 by $0.19. Learn more on analysts' earnings estimate vs. NVO's actual earnings.

The conference call for Novo Nordisk A/S's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Novo Nordisk A/S's latest earnings report can be read online.
Read Transcript

Novo Nordisk A/S (NYSE:NVO) has a recorded annual revenue of $46.80 billion.

Novo Nordisk A/S (NYSE:NVO) has a recorded net income of $15.51 billion. NVO has generated $4.09 earnings per share over the last four quarters.

Novo Nordisk A/S (NYSE:NVO) has a trailing price-to-earnings ratio of 11.25 and a forward price-to-earnings ratio of 13.56. The price/earnings-to-growth ratio is 4.3.

Novo Nordisk A/S's earnings are expected to decrease from $3.39 per share to $3.31 per share in the next year, which is a -2.36% change.

Related Companies
Earnings Tools

Earnings data for NYSE:NVO is sourced from Fiscal.ai, with the most recent quarter reported on 8/5/2026. New results are added as companies report their earnings.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
What's the Best Way to Lower RMD Taxes?
Once you turn 73, the IRS requires you to take distributions from your IRA, 401(k), and other retirement accou...
SmartAsset | Sponsoredtc pixel